Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1992-3-4
|
pubmed:abstractText |
Monoclonal antibody QBEND10 is reactive with the CD34 antigen in aldehyde-fixed, decalcified, paraffin-embedded bone marrow biopsies. In normal bone marrow it stained endothelial cells lining arterioles and capillaries, sinusoidal (littoral) cells and 0.89% of all haemopoietic cells. QBEND10+ mononuclear cells were seen as isolated, randomly distributed mononuclear cells in normal and regenerating bone marrows. Conversely, QBEND10+ cells were increased and present in aggregates of three or more cells in 6/8 cases of acute leukemia; in two cases of CD34-negative leukemia and in two patients after complete remission no aggregates were seen. QBEND10 immunohistochemistry may therefore be useful for diagnosis and follow-up of myeloid leukemias. In addition, increased numbers of CD34+ cells arranged in clusters were seen in 4/9 cases of refractory anemia with excess blasts (RAEB), 1 case of chronic myelomonocytic leukemia, 3/3 cases of RAEB in transformation, and in 3/7 cases of chronic myelogenous leukemia: in all these cases, CD34 staining of the bone biopsy may have prognostic value. QBEND10+ endothelial cells were significantly increased in all the pathological conditions examined (1.43% of all nucleated cells versus 0.80% in normal bone marrow; p = 0.0063), but especially in myeloid leukemias and in two fibrotic syndromes examined.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD34,
http://linkedlifedata.com/resource/pubmed/chemical/Fixatives,
http://linkedlifedata.com/resource/pubmed/chemical/Paraffin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0887-6924
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1026-30
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1723130-Anemia, Refractory, with Excess of Blasts,
pubmed-meshheading:1723130-Antibodies, Monoclonal,
pubmed-meshheading:1723130-Antigens, CD,
pubmed-meshheading:1723130-Antigens, CD34,
pubmed-meshheading:1723130-Biopsy,
pubmed-meshheading:1723130-Bone Marrow,
pubmed-meshheading:1723130-Bone Marrow Cells,
pubmed-meshheading:1723130-Fixatives,
pubmed-meshheading:1723130-Hematopoietic Stem Cells,
pubmed-meshheading:1723130-Humans,
pubmed-meshheading:1723130-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:1723130-Leukemia, Myeloid, Acute,
pubmed-meshheading:1723130-Myelodysplastic Syndromes,
pubmed-meshheading:1723130-Paraffin,
pubmed-meshheading:1723130-Primary Myelofibrosis
|
pubmed:year |
1991
|
pubmed:articleTitle |
Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody.
|
pubmed:affiliation |
Istituto di Scienze Mediche, University of Milano, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|